Unknown NA INTERVENTIONAL 2-arm NCT02799992

Pseudo-PDT in Central Serous Chorioretinopathy

Sponsor: Università degli Studi di Brescia

Conditions Chronic Central Serous Chorioretinopathy

Interventions 689 nm Laser Treatment of the Macula Half Dose Photodynamic Therapy

Updated 6 times since 2017 Last updated: Jun 9, 2016 Started: Jun 30, 2016 Primary completion: Sep 30, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02799992, this NA trial focuses on Chronic Central Serous Chorioretinopathy and remains ongoing. Sponsored by Università degli Studi di Brescia, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jul 2018 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Jul 2018 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Università degli Studi di Brescia

Data source: Università degli Studi di Brescia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.